• Recent Research/Demonstration Projects: To date there have been no clinical trials or demonstration projects of PrEP in Italy.
  • Drug Registration: Gilead (the manufacturer of Truvada) has not applied to the German regulatory agency for a prevention indication. The European Medicines Agency is in the process of reviewing Truvada for PrEP. The Agency is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union, but each member state will separately determine how, if at all, it might introduce PrEP.
  • Policy/Regulatory: There is no national PrEP policy or guidance at present.
  • Advocacy: Lila and Plus are two activist groups working on PrEP. Plus organized a public PrEP conference in Bologna and conducted surveys on community attitudes toward PrEP.

News Spotlight